Silberman David
SEC insider (Form 3/4/5 filer). CIK 0001867998. Chief Financial Officer at COMPUGEN LTD (CGEN) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 29, 2026. Located in HOLON.
Companies Silberman David has filed insider reports for
- COMPUGEN LTD (CGEN): Officer, Chief Financial Officer
- Nasus Pharma Ltd (NSRX): Director
Silberman David
CIK: 0001867998
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
